High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study-Reference-Cited by-同舟云学术

High acceptability and viral suppression of patients on Dolutegravir-based first-line regimens in pilot sites in Uganda: A mixed-methods prospective cohort study

Published:2020-05-27 Issue:5 Volume:15 Page:e0232419
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Nabitaka Vennie Mbaziira^ORCID,Nawaggi Pamela,Campbell Jennifer,Conroy James,Harwell Joseph,Magambo Kinanga,Middlecote Caroline,Caldwell Benvy,Katureebe Cordelia,Namuwenge Norah,Atugonza Rita,Musoke Andrew,Musinguzi Joshua

Funder

Unitaid

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference20 articles.

1. Uganda Ministry of Health. Quarterly Report. In: AIDS Control Programme S, editor. 2015.

2. Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa;MA Price;AIDS Res Hum Retroviruses,2011

3. Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients;AF Aghokeng;AIDS,2011

4. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study;PharmAccess African Studies to Evaluate Resistance (PASER);Lancet Infectious Diseases,2011

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of viral suppression and medication-related burden among HIV-infected adults in a secondary care facility;Exploratory Research in Clinical and Social Pharmacy;2024-09

2. Ensuring People Living with HIV Inform the Future of HIV Treatment in Low- and Middle-Income Countries: A Scoping Review and Recommendations for a Community-Led Research Agenda;AIDS and Behavior;2024-07-11

3. Liver function tests, CD4+ counts, and viral load among people living with HIV on dolutegravir compared to efavirenz-based cART; a comparative cross-sectional study;Heliyon;2024-06

4. Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana;Viruses;2024-05-01

5. Prevalence and factors associated with viral non‐suppression in people living with HIV receiving antiretroviral therapy in sub‐Saharan Africa: A systematic review and meta‐analysis;Reviews in Medical Virology;2024-05